Xinhang Gu
P.R. China
Jinan, 250117, China
Jinan, 250117, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identifying of Ubiquitin-Fold Modifier 1 as a Potential Prognostic Biomarker for Unresectable Pancreatic Cancer by Proteomics Analysis.
Journal: Cancer management and research
Published: October 31, 2025
Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC.
Journal: Frontiers in oncology
Published: September 18, 2025
Identifying Patients with EGFR-Mutated Oligometastatic NSCLC Suitable for Third-Generation EGFR-TKI Combined with Thoracic Radiotherapy Using Nomograms Based on CT Radiomic and Clinicopathological Factors.
Journal: Academic radiology
Published: September 17, 2025
Enhancing cancer risk awareness and screening management through artificial intelligence: a narrative review.
Journal: Frontiers in oncology
Published: August 30, 2025
Predicting the prognosis of patients with lung adenocarcinoma treated with third-generation EGFR-TKI alone using nomograms based on CT radiomic and clinicopathological factors.
Journal: Translational lung cancer research
Published: July 01, 2025
Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis.
Journal: Frontiers in oncology
Published: May 01, 2025
Immunotherapy in EGFR-mutant NSCLC after TKI resistance: role of mutation subtypes and progression patterns.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 21, 2025
Showing 1-8 of 8
Last Updated: 09/26/2026